The timing is close enough to probably not be a coincidence, IMHO. Note that it was only after NVS/MNTA filed the patent-infringement lawsuit that Teva began talking publicly about expecting a formal FDA response.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”